Compare CALM & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CALM | IDYA |
|---|---|---|
| Founded | 1957 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.6B |
| IPO Year | 1996 | 2019 |
| Metric | CALM | IDYA |
|---|---|---|
| Price | $72.96 | $38.38 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 16 |
| Target Price | ★ $92.00 | $52.86 |
| AVG Volume (30 Days) | ★ 867.2K | 666.6K |
| Earning Date | 04-01-2026 | 05-06-2026 |
| Dividend Yield | ★ 11.13% | N/A |
| EPS Growth | N/A | ★ 61.90 |
| EPS | ★ 6.63 | N/A |
| Revenue | ★ $2,911,632,000.00 | $218,710,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $201.05 |
| P/E Ratio | $11.17 | ★ N/A |
| Revenue Growth | N/A | ★ 3024.43 |
| 52 Week Low | $71.92 | $25.36 |
| 52 Week High | $101.50 | $42.68 |
| Indicator | CALM | IDYA |
|---|---|---|
| Relative Strength Index (RSI) | 30.71 | 49.84 |
| Support Level | N/A | $35.11 |
| Resistance Level | $80.00 | $40.58 |
| Average True Range (ATR) | 1.76 | 1.12 |
| MACD | -0.14 | -0.27 |
| Stochastic Oscillator | 3.52 | 28.82 |
Cal-Maine Foods Inc is an egg company in the U.S. Its shell egg portfolio includes conventional, specialty, cage-free, nutritionally enhanced, organic, brown, pasture-raised, and free-range eggs, serving retail and foodservice customers nationwide. It sells its products to national and regional grocery store chains, club stores, companies servicing independent supermarkets in the U.S., and foodservice distributors serving restaurants, convenience stores, healthcare and education facilities, and hotels throughout the majority of the U.S. The Conventional Shell Eggs segment generates maximum revenue and consists mainly of the production, grading, packaging, marketing, and distribution of shell eggs sold as conventional shell eggs.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.